Get started
Pro Medicus, Ltd.Pro Medicus, Ltd.Pro Medicus, Ltd.

Pro Medicus, Ltd.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

PMCUF chart

Upcoming earnings

Next report date
Report period
H2 2024
EPS estimate
0.27USD
Revenue estimate
‪55.71 M‬USD

Key stats

Market capitalization
‪7.32 B‬USD
Dividend yield (indicated)
0.32%
Price to earnings Ratio (TTM)
153.07
Basic EPS (TTM)
0.45USD
Net income (FY)
‪40.39 M‬USD
Revenue (FY)
‪83.18 M‬USD
Shares float
‪50.25 M‬
Beta (1Y)
1.22

About Pro Medicus, Ltd.

Sector
Health Services
Industry
Services to the Health Industry
CEO
Sam Aaron Hupert
Website
promedicus.com.au
Headquarters
Richmond
Founded
1983
ISIN
AU000000PME8
FIGI
BBG000H07L06
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. It provides services in the form of installation and support. The firm offers a range of products including radiology information systems, picture archiving and communication systems. It also offers workflow mapping and optimization, network design and implementation, hardware sourcing, and configuration as well as staff and management training. The company was founded by Sam Aaron Hupert and Anthony Barry Hall in 1983 and is headquartered in Richmond, Australia.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PMCUF is 69.25 USD — it has increased by 4.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pro Medicus, Ltd. stocks are traded under the ticker PMCUF.
Pro Medicus, Ltd. is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
PMCUF stock is 4.49% volatile and has beta coefficient of 1.22. Check out the list of the most volatile stocks — is Pro Medicus, Ltd. there?
PMCUF earnings for the last quarter are 0.21 USD per share, whereas the estimation was 0.20 USD resulting in a 4.23% surprise. The estimated earnings for the next quarter are 0.25 USD per share. See more details about Pro Medicus, Ltd. earnings.
Pro Medicus, Ltd. revenue for the last quarter amounts to ‪45.29 M‬ USD despite the estimated figure of ‪44.23 M‬ USD. In the next quarter revenue is expected to reach ‪52.40 M‬ USD.
Yes, you can track Pro Medicus, Ltd. financials in yearly and quarterly reports right on TradingView.
PMCUF stock has risen by 6.53% compared to the previous week, the month change is a 8.64% rise, over the last year Pro Medicus, Ltd. has showed a 64.49% increase.
PMCUF net income for the last quarter is ‪24.68 M‬ USD, while the quarter before that showed ‪22.28 M‬ USD of net income which accounts for 10.75% change. Track more Pro Medicus, Ltd. financial stats to get the full picture.
Today Pro Medicus, Ltd. has the market capitalization of ‪7.32 B‬, it has increased by 2.83% over the last week.
Pro Medicus, Ltd. dividend yield was 0.46% in 2023, and payout ratio reached 51.64%. The year before the numbers were 0.52% and 51.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, PMCUF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pro Medicus, Ltd. stock right from TradingView charts — choose your broker and connect to your account.
PMCUF reached its all-time high on Apr 9, 2024 with the price of 73.04 USD, and its all-time low was 0.30 USD and was reached on Mar 16, 2011.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pro Medicus, Ltd. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pro Medicus, Ltd. stock shows the buy signal. See more of Pro Medicus, Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Pro Medicus, Ltd. future price: according to them, PMCUF price has a max estimate of 98.26 USD and a min estimate of 37.24 USD. Read a more detailed Pro Medicus, Ltd. forecast: see what analysts think of Pro Medicus, Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pro Medicus, Ltd. EBITDA is ‪70.82 M‬ USD, and current EBITDA margin is 73.50%. See more stats in Pro Medicus, Ltd. financial statements.